Abstract
<b>Background:</b> Opioid-related deaths are increasing globally and are usually caused by respiratory failure. <b>Aims & Objectives:</b> To investigate risk factors for respiratory depression (RD) in Opioid Use Disorder (OUD) through study of the relationship between RD and drug use characteristics. <b>Methods:</b> Four groups were compared (Table 1): OUD with comorbid COPD (OUD-COPD, n=13); OUD without COPD (OUD, n=7); opioid-naïve COPD patients (COPD, n=13); and healthy controls (HC, n=7). SpO<sub>2</sub>%, end-tidal CO<sub>2</sub> (ETCO<sub>2</sub>), transcutaneous CO<sub>2</sub> (TcCO<sub>2</sub>), respiratory airflow and neural respiratory drive index (NRDI) derived from 2<sup>nd</sup> intercostal space parasternal muscle electromyography were recorded continuously during resting tidal breathing. RD was defined as any of: ETCO<sub>2</sub> per breath >6.6kPa, TcCO<sub>2</sub> >6kPa, apnoea or SpO<sub>2</sub>%<90% for >10s. <b>Results:</b> RD indices were observed in all OUD-COPD and OUD participants, but in only 2/7 HC and 2/13 COPD patients. Results of bivariate correlation analysis are shown in Table 2. <b>Conclusions:</b> Our data suggest that RD is common in OUD and is influenced by opioid agonist treatment dose and drug use duration. Capnography and NRDI are potentially useful to the study of overdose risk.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.